Empleo de probióticos en pediatría

1. Suarez JE. Microbiota autóctona, probióticos y prebióticos. Nutr Hosp 2013; 28 (Suppl. 1): s38-s41.

2. Johnson CL, Versalovic J. The human microbiome and its potential importance to pediatrics. Pediatrics 2012; 129: 950-60.

3. Ringel-Kulka T. Targeting the intestinal microbiota in the pediatric population: a clinical perspective. Nutr Clin Pract 2012;27: 226-34.

4. Thomas DW, Creer FR and Comité on Nutrition. Probiotics and prebiotics in Pediatrics. Pediatrics 2010; 126: 1217-31.

5. Floch MH, Walker WA, Madsen K, Sanders ME, Macfarlane GT, Flint HJ et al. Recommendations for probiotic use-2011 update. J Clin Gastroenterol 2011; 45: S 168-71.

6. WGO. Probióticos y prebióticos. En: Guías Mundiales de la Organización Mundial de Gastroenterología. Octubre 2011. www.Worldgastroenterology.org/probiotics-prebiotics.html.

7. Ciorba MA. A gastroenterologist’s guide to probiotics. Clin Gastroenterol Hepatol 2012; 10: 960-8.

8. Pies´cik-Lech M, Shamir R, Guarino A, Szajewska H. Review Article: The Management of Acute Gastroenteritis in Children. Aliment Pharmacol Ther 2013; 37: 289-303.

9. Guarino A, AMlbano F, Ashkenazi S, et al. European Society for Paediatric Gatroenterology, Hepatology and Nutrition/ European Society for Paediatric Infectious Diseases Guidelines for the Management of Acute Gastroenteritis in Children in Europe. J Pediatr Gastroentrol Nutr 2008; 46 (Suppl. 2): s81-s122.

10. Cincinnati Children s Hospital Medical Center. Evidence based clinical practice guideline for children with acute gastroenteritis (AGE). Cincinnati (OH) 2005: Guideline 5; pp. 1-15.

11. Khanna R, Lakhanpaul M, Burman-Roy S, Murphy MS. Diarrhoea and vomiting caused by gastroenteritis in children under 5 years: summary of NICE guidance. BMJ 2009; 338: b1350. doi: 10.1136/bmj.b1350.

12. Guandalini S. Probiotics for Children With diarrhea. An Update. J Clin Gastroenterol 2008; 42: 53-7.

13. Allen SJ, Martínez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010; (11): CD003048.

14. Szajewska, H, Skorka, A, Dylag, M. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007; 25: 257-64.

15. Szajewska, H, Skorka, A, Ruszczynski, M, Gieruszczak-Bialek, D. Meta-analysis: Lactobacillus GG for reating acute diarrhoea in children. Aliment Pharmacol Ther 2007; 25: 871-81.

16. Dubey AP, Rajeshwari K, Chakrsvarty A, Famularo G. Use of VSL#3 in the treatment of rotavirus diarrhea in children: preliminary results. J Clin Gastroenterol 2008; 42: 126-9.

17. Alam S, Mushtaq M. Antibiotic-associated diarrhea in children. Indian Pediatr 2009; 46: 491-6. Review.

18. Szajewska H, Wanke, M Patro B. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharmacol Ther 2011; 34: 1079-87.

19. Szajewska H, Ruszczynski M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 2006; 149: 367-72.

20. Johnston B, Goldenberg J, Vandvik P, Sun X, Guyatt G. Probióticos para la prevención de la diarrea asociada con antibióticos en niños. Cochrane Database of Systematic Reviews 2011 Issue 11. Art. No.: CD004827. DOI: 10.1002/14651858.CD004827.

21. Novak J, Katz JA. Probiotics and prebiotics for gastrointestinal infections. Curr Infect Dis Rep 2006; 8: 103-9.

22. Kachrimanidou M, Malisiovas N. Clostridium difficile infection: a comprehensive review. Crit Rev Microbiol 2011; 37:178-87.

23. Hickson M. Probiotics in the prevention antibiotic-associated diarrhoea and Clostridium difficile. Therap Adv Gastroenterol 2011; 4: 185-97.

24. Lynne V McFarland. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol2010; 16: 2202-22.

25. Surawicz CHM. The Search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii. Clinical Infectious Diseases 2000; 31: 1012-7.

26. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhoea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101: 812-22.

27. Wult M. Activity of 3 desinfectants and acidified nitrite against Clostridium difficile spores. Infect Control Hosp Epidemiol 2003; 24: 765-8.

28. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-9.

29. Angulo S, Sans M. Microbiota intestinal y enfermedad inflamatoria intestinal. Enf Inf Intestinal al día 2008; 7: 5-9.

30. Guarner F. Microbiota intestinal y enfermedades inflamatorias del intestino. Gastroenterol Hepatol 2011; 34: 147-154.

31. Burruel N. Probioticos en la enfermedad inflamatoria intestinal. Enf Inf Intestinal al día 2008; 7: 23-30.

32. Cain AM, Karpa KD. Clinical utility of probiotics in inflammatory bowel disease. Altern Ther Health Med 2011; 17: 72-9. Review.

33. Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009; 104: 437-43.

34. Oliva S Di Nardo G, Ferrari F, Mallardo S, Rossi P, Patrizi G et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther 2012; 35: 327-34.

35. Guandalini S. Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease. Expert Rev Clin Immunol 2010; 6: 47-54. Review.

36. Meijer BJ, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases: update 2011. J Clin Gastroenterol2011; 45 (Suppl): S139-44.572

37. Sartor RB. Probiotics for gastrointestinal diseases. www.uptodate.com 2013.

38. Verna CE, Lucak S. Use of probiotics in GI disorders: What to recommend? Therapeutic Advances in Gastroenterology 2010;3: 307-319.

39. Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N,Glasziou P. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 2009; 9: 15.

40. McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol2008; 14: 2650-61.

41. Guandalini S, Magazzù G, Cucchiara S, Gopalan S, Romano C, Canani RB et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicentre, randomized, placebocontrolled, double-blinded, cross-over study. JPGN 2010; 51: 24-30. doi: 10.1097/MPG.0b013e3181ca4d95.

42. Quigley EMM, Quera R. Small intestinal bacteria overgrowth: roles of antibiotics, prebiotics and probiotics. Gastrenterology 2006; 130: S78-90.

43. Vanderhoof JA, Sheng M, Wei C. Probiotics and Intestinal Inflammatory. Dis Inf Child 2000; 30: 34-8.

44. Bausserman M, MichailS. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatric 2005; 147: 197-201.

45. Gawro ska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment PharmacolTher 2007; 25: 177-84.

46. Francavilla R. A Randomized Controlled Trial of Lactobacillus GG in children with functional abdominal pain. J Pediatr 2011; 159: 165-6.

47. Bu LN, Chang MH, Ni YH, Chen HL, Cheng CC. Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. Pediatr Int 2007; 49: 485-90.

48. Tabbers MM, Chmielewska A, Roseboom MG, et al. Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre randomized controlled trial (NTRTC: 1571). BMC Pediatrics 2009; 9: 22.

49. Bekkali N, Bongers M, Van den Berg M et al. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study. Nutrition Journal 2007; 6: 17.

50. Tabbers MM, de Milliano I, Roseboom MG, Benninga MA. Is Bifidobacterium breve effective in the treatment of childhood constipation? Results from a pilot study. Nutrition Journal 2011; 10: 19.

51. Moore N, Chao C, Yang L et al. Effects of fructo-ologosaccharide- supplemented cereal: a double blind placebo controlled multinational study. Br J Nutr 2003; 90: 581-7.

52. Savino F, Cordisco L. Lactobacillus reuteri DSM Infantile Colic: A Randomized, Double- Blind Placebo-Controlled Trial. Pediatrics 2010; 126; e526; originally published online August 16, 2010.